CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) Asset Utilization Ratio (2019 - 2022)

Updated

CytoDyn's (CYDY) Asset Utilization Ratio was 0.00 for fiscal Q4 2022 (quarter ended May 31, 2022), up 81.0% from the prior quarter.

Analysis

CytoDyn (CYDY) Asset Utilization Ratio (2019 - 2022) Analysis & Trends

Dating back to fiscal Q1 2022, CytoDyn's Asset Utilization Ratio record includes 4 quarters.

  • Per Business Quant data, the three fiscal quarters before Q4 2022 came in at 0.00 (Q3 2022), 0.00 (Q2 2022) and 0.00 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 0.00
Feb 28, 2022 0.00
Nov 30, 2021 0.00
Aug 31, 2021 0.00
Feb 28, 2021 0.00
Nov 30, 2020 0.01
Aug 31, 2020 0.02
Nov 30, 2019 0.08
API Access

CytoDyn Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CYDY&period=max&api_key=YOUR_API_KEY